Forte Biosciences (FBRX) Non Operating Investment Income (2016 - 2020)
Forte Biosciences' (FBRX) quarterly Non Operating Investment Income came in at -$10000.0 in Q1 2020, down 124.39% year-on-year from $41000.0 in Q2 2019, and up 69.7% on a QoQ basis from -$33000.0 in Q4 2019.
Forte Biosciences (FBRX) Non Operating Investment Income (2016 - 2020) Analysis & Trends
Forte Biosciences (FBRX) has 5 years of Non Operating Investment Income data on file, last reported at -$10000.0 in Q1 2020.
- On a quarterly basis, Non Operating Investment Income fell 124.39% year-over-year to -$10000.0 in Q1 2020; TTM through Mar 2020 was -$18000.0, a 114.29% decrease from a year earlier, with the FY2019 full-year figure at $33000.0, up 200.0% from the prior year.
- Non Operating Investment Income for Q1 2020 stood at -$10000.0, up from -$33000.0 in the prior quarter.
- Over the last five years, Non Operating Investment Income for FBRX reached as high as $54000.0 in Q1 2016 and fell as low as -$74000.0 in Q1 2018.
- Historically, Non Operating Investment Income has averaged $3866.7 across 5 years, with a median of -$1000.0 in 2017.
- On a YoY basis, Non Operating Investment Income climbed as much as 1000.0% in 2018 and fell as far as 7300.0% in 2018.
- Year by year, Non Operating Investment Income stood at -$9000.0 in 2016, then plunged by 244.44% to -$31000.0 in 2017, then jumped by 200.0% to $31000.0 in 2018, then tumbled by 206.45% to -$33000.0 in 2019, then soared by 69.7% to -$10000.0 in 2020.
- Per Business Quant data, the three most recent Non Operating Investment Income figures were -$10000.0 in Q1 2020, -$33000.0 in Q4 2019, and -$13000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Forte Biosciences | 994.79 Mn | 936.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -10,000.00 |
| Mar 31, 2020 | -10,000.00 |
| Dec 31, 2019 | -33,000.00 |
| Dec 31, 2019 | -33,000.00 |
| Sep 30, 2019 | -13,000.00 |
| Sep 30, 2019 | -13,000.00 |
| Jun 30, 2019 | 38,000.00 |
| Jun 30, 2019 | 38,000.00 |
| Mar 31, 2019 | 41,000.00 |
| Mar 31, 2019 | 41,000.00 |
| Sep 30, 2018 | 31,000.00 |
| Sep 30, 2018 | 31,000.00 |
| Jun 30, 2018 | 54,000.00 |
| Jun 30, 2018 | 54,000.00 |
| Mar 31, 2018 | -74,000.00 |
| Mar 31, 2018 | -74,000.00 |
| Dec 31, 2017 | -31,000.00 |
| Dec 31, 2017 | -31,000.00 |
| Sep 30, 2017 | 4,000.00 |
| Sep 30, 2017 | 4,000.00 |